DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages
Author: Dr Katherine Allnutt, Resident Medical Officer, Monash Health, Melbourne, Australia. DermNet NZ Editor in Chief: Adjunct A/Prof Amanda Oakley, Dermatologist, Hamilton, New Zealand. Copy edited by Gus Mitchell/Maria McGivern. February 2018.
Listeriosis is a bacterial infection caused by the bacteria Listeria monocytogenes. Listeriosis is typically a food-borne illness and usually affects those with impaired immunity. Its presentation may range from febrile gastroenteritis to potentially fatal invasive disease, including sepsis, central nervous system infection, and perinatal infection .
Listeriosis may also uncommonly present with cutaneous eruptions.
Most cases of reported listeriosis are sporadic but a number of outbreaks have occurred .
Clinical listeriosis mostly occurs in high-risk groups including :
L. monocytogenes is an anaerobic gram-positive bacillus found in vegetation, soil, and animals. The consumption of contaminated food is thought to be the main route of transmission. The bacterium can survive acidic, salty, and cold food-processing techniques and can continue multiplying even with proper refrigeration . The incubation period for listeriosis is variable, and outbreaks have occurred 3–70 days following exposure to contaminated food products . The median incubation period is approximately 3 weeks.
The following foods are considered high-risk products :
L. monocytogenes may also be transmitted from mother to baby, via the placenta or vaginal infection .
Rarely, L. monocytogenes may also be transmitted from animals to humans .
Most cases of cutaneous listeriosis in adults result from direct inoculation of the skin . This is most commonly seen in veterinarians or farmers who come in contact with birthing animals, products related to animal conceptions and births, or soil carrying the bacteria. Cutaneous listeriosis may also result from invasive diseases spread through the bloodstream of individuals with impaired immunity .
In immunocompetent individuals, non-invasive listeriosis typically manifests as febrile gastroenteritis with self-limiting nausea, vomiting, and diarrhoea .
Maternal T-cell immunity is most affected during the third trimester and this is when listeriosis in pregnancy typically occurs .
Cutaneous listeriosis typically presents as purpuric, papulopustular, or vesiculopustular eruptions that are painless and non-pruritic .
Listeriosis is diagnosed by isolating L. monocytogenes from a site that is normally sterile, such as the patient's blood, cerebrospinal fluid (the fluid between the brain and spinal cord), gastric washings (results of a stomach pump), amniotic fluid (the liquid that surrounds the fetus in the womb), meconium (the first fecal material from a fetus), placenta or fetal tissue specimens . The bacterium may also be isolated from a skin biopsy.
Histopathology may demonstrate:
An elevated white-cell count on full blood examination is usually found.
Imaging may show abscesses on the patient's internal organs, such as the liver and brain.
Listeriosis presents like many other infectious diseases that cause fever and constitutional symptoms. The differential diagnosis for cutaneous listeriosis is wide and may include:
Listeriosis is treated with antibiotics.
Penicillin alone, or with gentamicin, is considered the drug of choice for the treatment of listeriosis. Vancomycin, meropenem, and linezolid have also been used successfully in case reports [1,11,12,13]. In patients who are allergic to penicillin, trimethoprim-sulphamethoxazole, or erythromycin may be used . L. monocytogenes is resistant to cephalosporins.
The duration of treatment varies depending on the patient's age and the location and severity of the illness.
There is limited evidence on the role of antibiotics in primary cutaneous listeriosis, but it has been proposed that a 5–7 day course of oral amoxicillin or trimethoprim–sulfamethoxazole may be warranted .
Listeriosis should be notified to the relevant local authorities . If contaminated products are implicated, these may need to be recalled.
Immunisation for listeriosis is not currently available.
Listeriosis is usually a self-limiting disease in immunocompetent individuals; however, the mortality rates in invasive disease may be as high as 20% . One third of cases of listeriosis in pregnancy result in miscarriage or stillbirth .
Primary cutaneous listeriosis usually resolves without long-term consequence .
See the DermNet NZ bookstore.
© 2020 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.